Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 2
2015 2
2016 3
2017 1
2018 1
2019 4
2020 3
2021 2
2022 6
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean liang dao ye (1 results)?
Response to Chen et al.
Ye L, Reiter FP, Guba M, De Toni EN. Ye L, et al. Clin Transl Gastroenterol. 2020 Aug;11(8):e00205. doi: 10.14309/ctg.0000000000000205. Clin Transl Gastroenterol. 2020. PMID: 32955201 Free PMC article. No abstract available.
TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status.
Ben Khaled N, Hammer K, Ye L, Alnatsha A, Widholz SA, Piseddu I, Sirtl S, Schneider J, Munker S, Mahajan UM, Montero JJ, Griger J, Mayerle J, Reiter FP, De Toni EN. Ben Khaled N, et al. Among authors: ye l. Cancers (Basel). 2022 Oct 26;14(21):5240. doi: 10.3390/cancers14215240. Cancers (Basel). 2022. PMID: 36358659 Free PMC article.
Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner" [Canc. Lett. 371 (2016) 354-365].
Zheng S, Chen H, Wang Y, Gao W, Fu Z, Zhou Q, Jiang Y, Lin Q, Tan L, Ye H, Zhao X, Luo Y, Li G, Ye L, Liu Y, Li W, Li Z, Chen R. Zheng S, et al. Among authors: ye l. Cancer Lett. 2022 Oct 1;545:215859. doi: 10.1016/j.canlet.2022.215859. Epub 2022 Aug 6. Cancer Lett. 2022. PMID: 35940956 No abstract available.
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Reiter FP, Denk G, Ziesch A, Ofner A, Wimmer R, Hohenester S, Schiergens TS, Spampatti M, Ye L, Itzel T, Munker S, Teufel A, Gerbes AL, Mayerle J, De Toni EN. Reiter FP, et al. Among authors: ye l. Cell Oncol (Dordr). 2019 Oct;42(5):705-715. doi: 10.1007/s13402-019-00458-8. Epub 2019 Jun 27. Cell Oncol (Dordr). 2019. PMID: 31250364
22 results